Complement your therapy with personalized microbiome solutions
Our advanced clinical-grade microbiome sequencing, intelligence, and profiling technology focuses on understanding and modulating the microbiome to optimize immune function and complement the therapies for digestive conditions & cancer.
Our top expertise
We detect each patient's dynamic inflammatory microbiome signatures connected with their medical condition.
We predict the impact load of the microbiome on the immune system.
We provide recommendations on how to reduce the impact through precise changes that alter the microbiome signatures and enhance the effectiveness of existing therapies.
Our focus is on IBD and Oncology, targeting in the future a few other medical conditions.
Endorsed by industry leaders
Dr. Razvan Curca
Medical Oncology
Board Advisor
President of SNOMR
The National Society for Medical Oncology in Romania
Dr. Belei Oana
Gastroenterology
Board Advisor
Pediatric Gastroenterologist at Louis Turcanu Emergency Pediatric Hospital, Timisoara
Isabella Grosu
Patients Representation
Board Advisor
President of the ASPIIR
Romanian Asociation for IBD Patients
Camelia Isaic
Corporate Development
Board Advisor
Investor relations, fundraising, grant management, social impact and corporate relations
Your gut microbiome contains vital signals and insights unique to your health.
Our science and technology are engineered to detect and decode the unique hidden chemical signals produced by your microbiome—signals that not only influence your health but also play a crucial role in immune system interactions. By understanding and modifying these signals, we can directly enhance your therapy outcomes.
The most advanced microbiome technology ever built for digestive health & cancer
The NostraBiome technology is the only one in the world that combines microbiome data, DNA data, blood data and advanced user profiling with established foundational medical data, but also frontier research and discoveries to detect dynamic inflammatory microbiome signatures of each patient and predict the load impact on the immune system, and most importantly recommend precise changes to alter those signatures and boost the impact on the existing therapies for cancer and digestive problems
How does it work for you ?
1. Choose your microbiome relevant product
Looking to start with just the test? No problem. You'll have the option to order any of our Personalized Solutions anytime after you've received your test results.
2. Register your test kit on our site
Registering your test will ensure we can connect your samples to you when they arrive at our CLIA-certified lab.
3. Collect your sample at home
Collect samples at home and send them to our lab
Everything you need to collect and ship your samples will be included in your test kit. No lab visit is required! We'll include a step-by-step guide and instruction videos to help you.
4. Fill in the online profiling questionnaire
Your questionnaire helps us further refine your recommendations and preferences, but most importantly understand the signals of your disease. Here you'll let us know about any medications you're taking or allergies you may have.
5. Recieve your personalized modulation strategy
The DNA sequencing of your profile requires a few weeks due to the complexity and vast amount of microbes we are looking at. After we combine all the medical data, questionaire, and microbiome we will send you a full report of what to do to change your microbiome, why and how. This will also arrive to your doctor who will integrate it as a complement to your existing therapy.
Who we are
We are a health and technology company uniting scientific advancements, artificial intelligence, biology, genetics, and medicine. Our mission is to harness microbiome insights as a key factor in enhancing therapies for inflammatory bowel disease, cancer, and oral health, significantly improving the efficacy of existing treatments and bringing hope to millions.
We believe advanced personalization and microbiome modulation will lead to a revolution in health
We leverage AI, DNA testing, advanced data profiling, and applied science to accelerate the ability of patients worldwide to complement their therapies. By doing so, we significantly enhance the likelihood of success for conditions where standard treatments have traditionally offered limited effectiveness, such as IBD, cancer, and autoimmune diseases.